| Catalog No. |
Size |
Price |
Figures |
|---|
Z02012-1 mg
| 1 mg | $ 105.00 |
References:
- Asres K, Bucar F. Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle. Ethiop. Med. J. Jan 2005; 43(1): 15-20.
- Olumide YM, et al. Seroprevalence study of HIV-I, HIV-II and HTLV-I among patients at the Dermato-Venereology Clinic of the Lagos University Teaching Hospital. Int. J. Dermatol. Oct 1997; 36(10): 741-744.
|
|---|
| Full Name | | Human Immunodeficiency Virus (HIV)-2 gp36 Envelope (synthetic) |
|
| Abbreviated Name-1 | HIV-II gp36 envelope (synthetic) |
|---|
| Description | GenScript Human Immunodeficiency Virus (HIV)-2 gp36 Envelope (synthetic) containing the HIV-2 specific sequence of gp36. It detects most of HIV-2 infected individuals responding to HIV-2 envelope proteins. |
|---|
| Purity | Reagent is >95% pure As determined by HPLC-C18, and MASS Analysis. |
|---|
| Storage | Reagent is shipped at ambient temperature. Freeze upon arrival. Store at -20°C. |
|---|
| Concentration | 1 mg/ml in H2O. |
|---|
| Stability | Five years frozen. One month in solution at 4°C. |
|---|
| Specificity | Immunoreactive with all sera of HIV-2 infected individuals. |
|---|
| Applications | Antigen in Rapid Tests, ELISA, and Western blots (as a conjugant). |
|---|
